- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anavex Life Sciences Corp (AVXL)
Assess today's live Anavex Life Sciences Corp (AVXL) share price, performance and insights using our live NASDAQ: AVXL stock exchange data.
Analyse the historical data and Anavex Life Sciences Corp share price performance charts on this page. Our technical summary section provides analysis on Anavex Life Sciences share price buy/sell indicators using real-time data (or discuss the Anavex Life Sciences (AVXL) stock price today with other investors in the Anavex Life Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ AVXL share price (ISIN: US0327973006) to enhance your trading decisions with our free investment tools and resources.
What Is the Anavex Life Sciences Corp Share Price Today?
The Anavex Life Sciences share price today is 3.340.
What Is the Stock Symbol for Anavex Life Sciences Corp
The stock symbol (or 'ticker') for Anavex Life Sciences Corp is "AVXL."
What Stock Exchange Does Anavex Life Sciences Corp Trade On?
Anavex Life Sciences Corp is listed and trades on the NASDAQ stock exchange.
Is Anavex Life Sciences Corp a Good Stock to Buy?
Determining whether Anavex Life Sciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Anavex Life Sciences Corp share price performance charts on this page. Our technical summary section provides analysis on Anavex Life Sciences share price buy/sell indicators using real-time data (or discuss the Anavex Life Sciences (AVXL) stock price today with other investors in the Anavex Life Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ AVXL share price (ISIN: US0327973006) to enhance your trading decisions with our free investment tools and resources.
What Is the Anavex Life Sciences Corp Share Price Today?
The Anavex Life Sciences share price today is 3.340.
What Is the Stock Symbol for Anavex Life Sciences Corp
The stock symbol (or 'ticker') for Anavex Life Sciences Corp is "AVXL."
What Stock Exchange Does Anavex Life Sciences Corp Trade On?
Anavex Life Sciences Corp is listed and trades on the NASDAQ stock exchange.
Is Anavex Life Sciences Corp a Good Stock to Buy?
Determining whether Anavex Life Sciences Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.230
3.410
52 wk Range
2.610
13.990
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.2303.410
52 wk Range
2.61013.990
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AVXL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
22.000
Upside
+558.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The company’s ANAVEX 3-71, which targets SIGMAR1 and M1 muscarinic receptors, is a clinical stage drug candidate demonstrating disease-modifying activity against Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
Anavex Life Sciences Corp Earnings Call Summary for Q1/2026
- Anavex Life Sciences reported Q1 2026 EPS of -$0.06, surpassing the forecasted -$0.12, with a strong cash position of $131.7 million and no debt.
- R&D expenses decreased significantly from $10.4 million to $4.7 million, demonstrating improved operational efficiency as the company advances its pipeline.
- Despite positive earnings, Anavex's stock showed a minor premarket decline of 0.24%, trading at $4.09 within its 52-week range of $2.86-$13.99.
- The company continues to advance oral blarcamesine for early Alzheimer's disease and plans to initiate trials for Parkinson's Disease, Fragile X Syndrome, and Schizophrenia.
- CEO Dr. Christopher Missling emphasized focus on execution while acknowledging challenges including ongoing EMA re-examination and potential clinical trial delays.
Last Updated: 09/02/2026, 14:18
Read Full TranscriptCompare AVXL to Peers and Sector
Metrics to compare | AVXL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVXLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.7x | −1.6x | −0.5x | |
PEG Ratio | −0.48 | −0.01 | 0.00 | |
Price/Book | 2.4x | 2.3x | 2.6x | |
Price / LTM Sales | - | 44.7x | 3.2x | |
Upside (Analyst Target) | - | 217.1% | 47.4% | |
Fair Value Upside | Unlock | 14.9% | 7.7% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 22.000
(+558.68% Upside)
Earnings
Latest Release
09/02/2026
EPS / Forecast
-0.06 / -0.12
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Anavex Life Sciences (NASDAQ: AVXL) Share Price Today?
The Anavex Life Sciences stock price today is 3.340 USD.
What Stock Exchange Does Anavex Life Sciences (AVXL) Trade On?
Anavex Life Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Anavex Life Sciences?
The stock symbol (also called a 'ticker') for Anavex Life Sciences is "AVXL."
What Is the Current Anavex Life Sciences Market Capitalisation?
As of today, Anavex Life Sciences (NASDAQ: AVXL) market cap is 309.520M USD.
What Is Anavex Life Sciences's (AVXL) Earnings Per Share (TTM)?
The Anavex Life Sciences EPS is currently -0.463 (Trailing Twelve Months).
When Is the Next Anavex Life Sciences Earnings Date?
Anavex Life Sciences's next earnings report will be released on 07/05/2026.
Is AVXL a Buy or Sell From a Technical Analyst Perspective?
Based on today's Anavex Life Sciences moving averages and other technical indicators, the daily buy/sell signal for AVXL stock is Sell.
How Many Times Has Anavex Life Sciences Stock Split?
Anavex Life Sciences has split 2 times. (See the AVXL stock split history page for full effective split date and price information.)
How Many Employees Does Anavex Life Sciences Have?
Anavex Life Sciences has 34 employees, based on their latest Companies House report.
What is the current trading status of Anavex Life Sciences (NASDAQ: AVXL)?
As of 25/04/2026, Anavex Life Sciences (AVXL) is trading at a share price of 3.340 USD, with a previous close of 3.310 USD. The stock has fluctuated within a day range of 3.230 USD to 3.410 USD, while its 52-week range spans from 2.610 USD to 13.990 USD.
What Is Anavex Life Sciences (AVXL) Price Target According to Analysts?
The average 12-month price target for Anavex Life Sciences is 22.000 USD, with a high estimate of 24 USD and a low estimate of 20 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +558.68% Upside potential.
What Is the AVXL Premarket Price?
AVXL's last pre-market stock price is 3.333 USD. The pre-market share volume is 1,000.000, and the stock has decreased by 0.023, or 0.690%.
What Is the AVXL After Hours Price?
AVXL's last after hours stock price is 3.404 USD, the stock has decreased by 0.064, or 1.930%.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.